Idéal Investisseur
Français English
CAC 40 : Market open
8 177,59 pts
-0.31%


Last updated : 10/06/2026 - 14h23
🏠 Home   ➤    Stock news

Eurofins Scientific Shares: 2.19% Decline at Close Despite a Positive Week

Eurofins Scientific shares ended the Tuesday, October 21 session down by 2.19%, closing at 62.50 euros compared to 63.90 euros the previous day. This decline goes against the trend of the Parisian market, as the CAC 40 rose by 0.64% at the same time to reach 8,258.86 points. This daily performance contrasts with the weekly dynamics of the analysis laboratory specialist, which still shows a rise of 1.23% over seven days.


Eurofins Scientific Shares: 2.19% Decline at Close Despite a Positive Week

Limited Capital Turnover and Market Divergence

Trading in Eurofins Scientific shares was marked by limited capital turnover, with only 0.42% of shares changing hands during the session. This low activity accompanies a downward movement that brings the price back to 62.50 euros, erasing some of the gains accumulated since the beginning of the week. Over a three-month horizon, the stock still maintains a gain of 1.86%, while the annual performance stands at 10.78%, thus exceeding the 8.48% rise recorded by the CAC 40 index over the same period. The decline observed this Tuesday is set against a bullish market context, highlighting the divergence between the group's trajectory and that of the Parisian market. The beta coefficient of -0.04 indeed reflects an almost absence of correlation between the variations of Eurofins Scientific and those of the benchmark index. This technical characteristic is verified once again today, as the stock moves independently from the general trend of the French equity markets.

Technical Analysis Highlights

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

From a technical analysis standpoint, the day's significant event was the crossing below the 50-day moving average. The closing price at 62.50 euros is now below this threshold, positioned at 63.83 euros, signaling a weakening of the short-term momentum. However, the stock still trades above its 200-day moving average, set at 57.11 euros, thus preserving a favorable underlying trend since the beginning of the year. The approach to the technical support threshold identified at 60.80 euros deserves attention, with the price now approaching less than three percent away. Conversely, the resistance at 64.00 euros remains out of immediate reach after today's decline. The Relative Strength Index shows a value of 62, maintaining a neutral zone that indicates neither overbought nor oversold conditions. The MACD maintains a positive setup with a main line at 0.17 above its signal line at 0.05, while the positive histogram at 0.13 suggests the continuation of an underlying bullish momentum. The price moves within the Bollinger Bands, ranging from 60.66 euros to 63.81 euros, indicating contained volatility established at 5.51 over a month.



Sector Santé · Vaccins et laboratoires de recherche Services médicaux


Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext

Contexte

Period
  • Period: 1T2026
Key reported figures
  • Revenue: 1789M€
Guidance from the release
  • Eurofins a rencontré des vents contraires importants et temporaires.
  • Malgré une croissance organique modérée, la rentabilité et les marges progressent.
Risks mentioned
  • Baisse de la demande en raison de conditions climatiques défavorables en Amérique du Nord.
  • Rationalisation des contrats dans les diagnostics cliniques en Espagne et en Italie.
Opportunities identified
  • Lancement de nouveaux contrats renforçant notre portefeuille BioPharma.
  • Initiatives de digitalisation et amélioration du réseau de laboratoires.

Les informations présentées dans cet article sont fournies à titre purement indicatif et ne constituent en aucun cas une recommandation d'investissement, une incitation à acheter ou vendre un actif financier, ni un conseil en placement. Le lecteur est invité à réaliser ses propres recherches avant toute décision.

Les investissements en bourse comportent des risques, notamment de perte en capital. La performance passée d'un actif ou d'un marché ne présage en rien de ses performances futures. Toute décision d'investissement doit être prise en tenant compte de votre situation financière personnelle, de vos objectifs et de votre tolérance au risque.

Annonce
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours